![Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study](https://www.frontiersin.org/files/Articles/858202/fonc-12-858202-HTML/image_m/fonc-12-858202-g001.jpg)
Frontiers | Outcomes of Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Hypomethylating Agents With or Without Venetoclax: A Propensity Score-Adjusted Cohort Study
![Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/1349fd45-d3d6-4ead-92fb-ef79bef030dc/gr1.jpg)
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation
![Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1556086421022863-gr1.jpg)
Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC - ScienceDirect
![Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram](https://www.researchgate.net/publication/352175565/figure/fig4/AS:1031879062978561@1623030548093/Prognostic-benefit-of-stromal-and-epithelial-CD8CD103-TRM-infiltration-in-patient.png)
Prognostic benefit of stromal and epithelial CD8CD103 TRM infiltration... | Download Scientific Diagram
![Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/asset/c81e7fc1-104b-4bd5-898f-ae85d2a7b38a/gr41.jpg)
Very Young Children Who Undergo Hematopoietic Cell Transplantation at Weight Extremes Have Inferior Overall Survival and Increased Transplant Related Morality - Biology of Blood and Marrow Transplantation
![Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation](https://www.frontiersin.org/files/Articles/444876/fimmu-10-01997-HTML/image_m/fimmu-10-01997-g001.jpg)
Frontiers | Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation
Is stem cell transplantation still needed for adult Philadelphia chromosome-positive acute lymphoblastic leukemia receiving tyrosine kinase inhibitors therapy?: A systematic review and meta-analysis | PLOS ONE
![Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/3c519893-23a9-4078-946a-1fd1e40feff8/gr3.jpg)
Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis - Annals of Oncology
![Cancers | Free Full-Text | Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy Cancers | Free Full-Text | Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy](https://www.mdpi.com/cancers/cancers-13-05142/article_deploy/html/images/cancers-13-05142-g004.png)
Cancers | Free Full-Text | Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy
![Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-019-0469-5/MediaObjects/41409_2019_469_Fig1_HTML.png)
Clinical impact of the loss of chromosome 7q on outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation
![Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2020642845/2040389631/gr1.jpg)
Treatment of Patients with Adult T Cell Leukemia/Lymphoma with Cord Blood Transplantation: A Japanese Nationwide Retrospective Survey - Biology of Blood and Marrow Transplantation
![Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/2052561563/2059830314/gr3.jpg)
Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years - Biology of Blood and Marrow Transplantation
![Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//23412879/0000009600000004/v2_202206220704/S2341287922000771/v2_202206220704/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w9/qVHBXBqbSQ7FNUvNof+6+l4v03CmyaR9Rm+q8TRfDERovN5wMUmDVyYvA+rI0XvMBqAhgbAUgPlLneQzJhNXQfB28hIz1d+g3e9TdeZbcpcgzN9ZQFyrecMywN4v0hqWnSw1vXLOvJoTkEvNx/ckpHkPBKuGIqSzrdNd2XTBqASNnXO8OIFMftXYHbFKXRK6osyXGJFZGECmEuQwJtg85l901lOp0hPwiRcRrEmhXfx0aORXzTPfzv/hjZ5/CFlP494w6TqOc5+mMuoewRQII=)
Experience of the Spanish Group for Hematopoietic Transplantation (GETMON-GETH) in allogenic Hematopoietic stem cell Transplantation in Philadelphia acute lymphoblastic leukemia | Anales de Pediatría
TRM, Relapse/Progression (1a), Progression Free and Overall Survival... | Download Scientific Diagram
![Outcomes by FLT3-ITD and NPM1 status LFS (a), OS (b), TRM (c), and RI... | Download Scientific Diagram Outcomes by FLT3-ITD and NPM1 status LFS (a), OS (b), TRM (c), and RI... | Download Scientific Diagram](https://www.researchgate.net/publication/341278287/figure/fig1/AS:958790098763790@1605604781901/Outcomes-by-FLT3-ITD-and-NPM1-status-LFS-a-OS-b-TRM-c-and-RI-d-by-molecular.png)
Outcomes by FLT3-ITD and NPM1 status LFS (a), OS (b), TRM (c), and RI... | Download Scientific Diagram
![Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2016.229/MediaObjects/41375_2017_Article_BFleu2016229_Fig1_HTML.jpg)
Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis | Leukemia
![A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram](https://www.researchgate.net/publication/347311399/figure/fig1/AS:1093215809740802@1637654368789/A-Overall-survival-OS-in-patients-who-received-10-day-decitabine-with-venetoclax.png)
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram
![Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00277-022-04817-8/MediaObjects/277_2022_4817_Fig4_HTML.png)
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation | SpringerLink
![A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram](https://www.researchgate.net/publication/347311399/figure/fig1/AS:1093215809740802@1637654368789/A-Overall-survival-OS-in-patients-who-received-10-day-decitabine-with-venetoclax_Q640.jpg)
A, Overall survival (OS) in patients who received 10‐day decitabine... | Download Scientific Diagram
![Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology](https://www.jto.org/cms/asset/3b4b3b7f-ef3e-49b2-b1e3-89793b6a8627/gr1.jpg)
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
![Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial - ScienceDirect Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1556086421000228-gr1.jpg)
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial - ScienceDirect
![Overall survival (OS) in elderly AML patients a OS according to period;... | Download Scientific Diagram Overall survival (OS) in elderly AML patients a OS according to period;... | Download Scientific Diagram](https://www.researchgate.net/publication/345940564/figure/fig3/AS:958461126914061@1605526348676/Overall-survival-OS-in-elderly-AML-patients-a-OS-according-to-period-b-OS-according-to.png)
Overall survival (OS) in elderly AML patients a OS according to period;... | Download Scientific Diagram
![Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/attachment/543fdedd-4892-4315-99d2-c0ee01315aaa/gr1.gif)